Skip to main content
Clinical Trials/CTRI/2026/02/104368
CTRI/2026/02/104368
Not yet recruiting
Not Applicable

Comparison between the efficacy of intravenous dexmedetomidine vs intravenous lignocaine on post operative analgesia in patients undergoing laparoscopic cholecystectomy

Dr Manchala Jyothi Sai Reddy1 site in 1 country86 target enrollmentStarted: March 2, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Dr Manchala Jyothi Sai Reddy
Enrollment
86
Locations
1
Primary Endpoint
1) Duration of analgesia

Overview

Brief Summary

This is a prospective observational study to compare intraoperative hemodynamic stability and postoperative analgesia using Intravenous lignocaine vs intravenous dexmedetomidine in patients undergoing laparoscopic cholecystectomy. The study is planned to be conducted at a tertiary hospital in Dakshina Kannada. The study will be carried out on patients aged 18 to 65 years of ASA grade I and II undergoing laparoscopic cholecystectomy. The study has already cleared the institutional ethics committee approval.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients aged 18 to 65 years of either sex with the American Society of Anesthesiologists physical status classes 1 and 2 undergoing elective laparoscopic cholecystectomy surgery.

Exclusion Criteria

  • Patients unwilling to participate in the study.
  • Patients with BMI more than 35 kgm2 3)History of hypersensitivity to the drugs 4)Parturient 5)Chronic use of opioids or opioid addiction, steroids.
  • Inability to comprehend postoperatively for the pain assessment scale or neuropsychiatric disorders.

Outcomes

Primary Outcomes

1) Duration of analgesia

Time Frame: Intraoperative assessment done at Baseline, After boluses of study drugs, Immediately after ETI, 5min, 15min, 30min, 45m, 1h, 1h15m, 1h30m, 1h45m, 2h, until the pneumoperitoneum is released. | Postoperatively assessed at 1hr, 4hr, 8hr, 12hr, and upto 24 hours

2) VAS score

Time Frame: Intraoperative assessment done at Baseline, After boluses of study drugs, Immediately after ETI, 5min, 15min, 30min, 45m, 1h, 1h15m, 1h30m, 1h45m, 2h, until the pneumoperitoneum is released. | Postoperatively assessed at 1hr, 4hr, 8hr, 12hr, and upto 24 hours

Secondary Outcomes

  • 1) Intraoperative Hemodynamic parameters at baseline, after boluses of drugs administration, immediately after intubation, 5min & every 15min until the end of the procedure.(2) Side effects like nausea, vomiting & sore throat.)

Investigators

Sponsor
Dr Manchala Jyothi Sai Reddy
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Manchala Jyothi Sai Reddy

Kasturba Medical College, Mangalore

Study Sites (1)

Loading locations...

Similar Trials